BIO KEY INTERNATIONAL INC (BKYI) Form 10-Q — Aug 13, 2026
BIO-key International (BKYI) filed its Q2 2026 10-Q showing revenue up 13% year over year to $1.92 million with the net loss narrowed to $576,852 from $1,167,396, and six-month revenue up 23% to $4.07 million on 36% license revenue growth. The company disclosed going-concern doubt, reporting just $1.38 million in cash against roughly $750,000 in monthly operating needs and stating it does not have enough cash for twelve months of operations, making additional financing necessary.
Key figures
- Revenue
- 1919991
- Cash Position
- 1379300
- Working Capital
- 793000
- Six Month Revenue
- 4065524
- Reverse Split Ratio
- 1:10
- Customer Concentration
- two customers = 52% of Q2 2026 revenue; two customers = 74% of accounts receivable
- Monthly Cash Requirement
- 750000
- Note Exchange Subsequent
- $350,000 of 2025 Note exchanged for 81,100 shares, leaving ~$325,000 outstanding
- Reserved Nigeria Inventory
- 2100000
- Shares Outstanding Aug2026
- 1436344
- Six Month Revenue Prior Year
- 3304066
- Subsequent Warrant Proceeds Aug2026
- approximately $2.5 million gross
Price after filing
Close on the filing date to close N calendar days later (from $3.77). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.